The effect of oral Contraceptive pills and the natural menstrual cYCLe on arterial stiffness and hemodynamICs (CYCLIC)

Journal of Hypertension

Volumn 32, Issue 1, 2014, Pages 100-107

  Yu, Alice ^a   Giannone, Tania ^a   Scheffler, Patrick ^a   Doonan, Robert J ^a   Egiziano, Giordano ^a   Gomez, Yessica Haydee ^a   Papaioannou, Theodore G ^b   Daskalopoulou, Stella S ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Aortic blood pressure; Arterial stiffness; Hemodynamics; Menstrual cycle; Oral contraceptive pill; Peripheral blood pressure; Phases of menstrual cycle

Indexed keywords

DROSPIRENONE PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; ETHINYLESTRADIOL PLUS NORGESTIMATE; MINESTRIN; TRI CYCLEN; UNCLASSIFIED DRUG;

ADULT; AORTA PRESSURE; ARTERIAL STIFFNESS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ELEVATED BLOOD PRESSURE; FEMALE; FOLLICULAR PHASE; HEMODYNAMICS; HUMAN; LOW DRUG DOSE; LUTEAL PHASE; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; TABLET; TONOMETRY; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD PRESSURE; CONTRACEPTIVES, ORAL; FEMALE; HEMODYNAMICS; HUMANS; MENSTRUAL CYCLE; VASCULAR STIFFNESS; YOUNG ADULT;

EID: 84891555410     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000012     Document Type: Article

References (50)

1. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991; 265:1861-1867
2. Wenger NK, Speroff L, Packard B. Cardiovascular health and disease in women. N Engl J Med 1993; 329:247-256
3. Giannattasio C, Failla M, Grappiolo A, Stella ML, Del Bo A, Colombo M, Mancia G. Fluctuations of radial artery distensibility throughout the menstrual cycle. Arterioscler Thromb Vasc Biol 1999; 19:1925-1929
4. Hayashi K, Miyachi M, Seno N, Takahashi K, Yamazaki K, Sugawara J, et al. Variations in carotid arterial compliance during the menstrual cycle in young women. Exp Physiol 2006; 91:465-472
5. Williams MR, Westerman RA, Kingwell BA, Paige J, Blombery PA, Sudhir K, Komesaroff PA. Variations in endothelial function and arterial compliance during the menstrual cycle. J Clin Endocrinol Metab 2001; 86:5389-5395
6. Ounis-Skali N, Mitchell GF, Solomon CG, Solomon SD, Seely EW. Changes in central arterial pressure waveforms during the normal menstrual cycle. J Invest Med 2006; 54:321-326
7. Papaioannou TG, Karatzis EN, Papamichael CM, Karatzi KN, Zakopoulos NA, Lekakis JP, et al. Circadian variation of arterial pressure wave reflections. Am J Hypertens 2006; 19:259-263
8. Papaioannou TG, Protogerou AD, Stamatelopoulos KS, Vavuranakis M, Stefanadis C. Noninvasive methods and techniques for central blood pressure estimation: Procedures, validation, reproducibility and limitations. Curr Pharm Des 2009; 15:245-253
9. Cherry N, Gilmour K, Hannaford P, Heagerty A, Khan MA, Kitchener H, et al. Oestrogen therapy for prevention of reinfarction in postmenopausal women: A randomised placebo controlled trial. Lancet 2002; 360:2001-2008
10. Lidegaard O, Lokkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: National follow-up study. BMJ 2009; 339:b2890; doi: 10.1136/bmj.b2890.: B2890
11. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives: Results of an international multicentre case-control study. Lancet 1997; 349:1202-1209
12. Heinemann LA, Lewis MA, Thorogood M, Spitzer WO, Guggenmoos-Holzmann I, Bruppacher R. Case-control study of oral contraceptives and risk of thromboembolic stroke: Results from International Study on Oral Contraceptives and Health of Young Women. BMJ 1997; 315: 1502-1504
13. Lidegaard O, Lokkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 2012; 366:2257-2266
14. Lizarelli PM, Martins WP, Vieira CS, Soares GM, Franceschini SA, Ferriani RA, Patta MC. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women. Contraception 2009; 79:35-40
15. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33:1111-1117
16. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: A longitudinal study. Hypertension 2002; 39:10-15
17. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: An integrated index of vascular function? Circulation 2002; 106:2085-2090
18. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37:1236-1241
19. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113:664-670
20. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, et al. Arterial stiffness and cardiovascular events: The Framingham Heart Study. Circulation 2010; 121:505-511
21. Mancia G, De BG, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28:1462-1536
22. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-Analysis. J Am Coll Cardiol 2010; 55:1318-1327
23. O'Rourke MF, Pauca A, Jiang XJ. Pulse wave analysis. Br J Clin Pharmacol 2001; 51:507-522
24. McEniery CM, Yasmin. McDonnell B, Munnery M, Wallace SM, Rowe CV, et al. Central pressure: Variability and impact of cardiovascular risk factors: The Anglo-Cardiff Collaborative Trial II. Hypertension 2008; 51:1476-1482
25. Protogerou AD, Papaioannou TG, Blacher J, Papamichael CM, Lekakis JP, Safar ME. Central blood pressures: Do we need them in the management of cardiovascular disease? Is it a feasible therapeutic target? J Hypertens 2007; 25:265-272
26. Cheng HM, Chuang SY, Sung SH, Yu WC, Pearson A, Lakatta EG, et al. Derivation and validation of diagnostic thresholds for central blood pressure measurements based on long-Term cardiovascular risks. J Am Coll Cardiol 2013. doi: 10.1016/j.jacc.2013.06.029
27. Reproductive endocrinology. Hoffman BL, Schorge JO, Schaffer JI, Halvorson LM, Bradshaw KD, Cunningham FG, editors. et al. Williams gynecology, 2nd edn. New York: McGraw-Hill; 2012
28. Daskalopoulou SS, Khan NA, Quinn RR, Ruzicka M, McKay DW, Hackam DG, et al. The 2012 Canadian hypertension education program recommendations for the management of hypertension: Blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2012; 28:270-287
29. Rabi DM, Daskalopoulou SS, Padwal RS, Khan NA, Grover SA, Hackam DG, et al. The 2011 Canadian hypertension education program recommendations for the management of hypertension: Blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2011; 27:415-433
30. Papaioannou TG, Protogerou AD, Nasothimiou EG, Tzamouranis D, Skliros N, Achimastos A, et al. Assessment of differences between repeated pulse wave velocity measurements in terms of 'bias' in the extrapolated cardiovascular risk and the classification of aortic stiffness: Is a single PWV measurement enough? J Hum Hypertens 2012; 26:594-602
31. Doonan RJ, Scheffler P, Yu A, Egiziano G, Mutter A, Bacon S, et al. Altered arterial stiffness and subendocardial viability ratio in young healthy light smokers after acute exercise. PLoS One 2011; 6: E26151
32. Crilly M, Coch C, Clark H, Bruce M, Williams D. Repeatability of the measurement of augmentation index in the clinical assessment of arterial stiffness using radial applanation tonometry. Scand J Clin Lab Invest 2007; 67:413-422
33. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001; 38:932-937
34. Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, Webb DJ. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998; 16:2079-2084
35. Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J 1993; 14:160-167
36. Benetos A, Thomas F, Joly L, Blacher J, Pannier B, Labat C, et al. Pulse pressure amplification a mechanical biomarker of cardiovascular risk. J Am Coll Cardiol 2010; 55:1032-1037
37. Avolio AP, Chen SG, Wang RP, Zhang CL, Li MF, O'Rourke MF. Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation 1983; 68:50-58
38. Hashimoto M, Akishita M, Eto M, Ishikawa M, Kozaki K, Toba K, et al. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 1995; 92:3431-3435
39. Willekes C, Hoogland HJ, Keizer HA, Hoeks AP, Reneman RS. Female sex hormones do not influence arterial wall properties during the normal menstrual cycle. Clin Sci (Lond) 1997; 92:487-491
40. Robb AO, Mills NL, Din JN, Smith IB, Paterson F, Newby DE, Denison FC. Influence of the menstrual cycle, pregnancy, and preeclampsia on arterial stiffness. Hypertension 2009; 53:952-958
41. Boldo A, White WB. Blood pressure effects of the oral contraceptive and postmenopausal hormone therapies. Endocrinol Metab Clin North Am 2011; 40:419-432; i.x.
42. Hickson SS, Miles KL, McDonnell BJ, Yasmin Cockcroft JR, Wilkinson IB, McEniery CM. Use of the oral contraceptive pill is associated with increased large artery stiffness in young women: The ENIGMA study. J Hypertens 2011; 29:1155-1159
43. Protogerou AD, Stergiou GS, Vlachopoulos C, Blacher J, Achimastos A. The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: Evidence for specific class-effects of antihypertensive drugs on pressure amplification. Curr Pharm Des 2009; 15:272-289
44. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113:1213-1225
45. Kaess BM, Rong J, Larson MG, Hamburg NM, Vita JA, Levy D, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA 2012; 308:875-881
46. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: The Strong Heart Study. Hypertension 2007; 50:197-203
47. Sandoval YH, Yu A, Daskalopoulou SS. Use of oral contraceptives and arterial stiffness. J Hypertens 2011; 29:2042-2044
48. Arruda CG, Aldrighi JM, Bortolotto LA, Alecrin IN, Ramires JA. Effects of estradiol alone and combined with norethisterone acetate on pulse-wave velocity in hypertensive postmenopausal women. Gynecol Endocrinol 2006; 22:557-563
49. Miura S, Tanaka E, Mori A, Toya M, Takahashi K, Nakahara K, et al. Hormone replacement therapy improves arterial stiffness in normotensive postmenopausal women. Maturitas 2003; 45:293-298
50. Teede HJ, Liang YL, Kotsopoulos D, Zoungas S, Craven R, McGrath BP. Placebo-controlled trial of transdermal estrogen therapy alone in postmenopausal women: Effects on arterial compliance and endothelial function. Climacteric 2002; 5:160-169